The	O
Puf	B-GP
-	O
Family	O
RNA	B-GP
-	I-GP
Binding	I-GP
Protein	I-GP
Puf2	B-GP
Controls	O
Sporozoite	O
Conversion	O
to	O
Liver	O
Stages	O
in	O
the	O
Malaria	B-DS
Parasite	O

Conceived	O
and	O
designed	O
the	O
experiments	O
:	O
K	O
.	O

Müller	O
K	O
.	O

Matuschewski	O
OS	O
.	O

Performed	O
the	O
experiments	O
:	O
K	O
.	O

Müller	O
OS	O
.	O

Analyzed	O
the	O
data	O
:	O
K	O
.	O

Müller	O
K	O
.	O

Matuschewski	O
OS	O
.	O

Wrote	O
the	O
paper	O
:	O
K	O
.	O

Matuschewski	O
OS	O
.	O

Current	O
address	O
:	O
INSERM	O
UMR_S	O
945	O
""""	O
Immunity	O
and	O
infection	B-DS
""","	O
Centre	O
Hospitalier	O
Universitaire	O
Pitié	O
-	O
Salpêtrière	O
,	O
Faculté	O
de	O
Médecine	O
et	O
Université	O
Pierre	O
et	O
Marie	O
Curie	O
,	O
Paris	O
,	O
France	O

Malaria	B-DS
is	O
a	O
vector	B-DS
-	I-DS
borne	I-DS
infectious	I-DS
disease	I-DS
caused	O
by	O
unicellular	O
,	O
obligate	O
intracellular	O
parasites	O
of	O
the	O
genus	O
Plasmodium	B-OG
.	O

During	O
host	O
switch	O
the	O
malaria	B-DS
parasite	O
employs	O
specialized	O
latent	O
stages	O
that	O
colonize	O
the	O
new	O
host	O
environment	O
.	O

Previous	O
work	O
has	O
established	O
that	O
gametocytes	O
,	O
sexually	O
differentiated	O
stages	O
that	O
are	O
taken	O
up	O
by	O
the	O
mosquito	B-OG
vector	O
,	O
control	O
expression	O
of	O
genes	O
required	O
for	O
mosquito	B-OG
colonization	O
by	O
translational	O
repression	O
.	O

Sexual	O
parasite	O
development	O
is	O
controlled	O
by	O
a	O
DEAD	B-GP
-	I-GP
box	I-GP
RNA	I-GP
helicase	I-GP
of	O
the	O
DDX6	B-GP
family	O
,	O
termed	O
DOZI	B-GP
.	O

Latency	O
of	O
sporozoites	O
,	O
the	O
transmission	O
stage	O
injected	O
during	O
an	O
infectious	O
blood	O
meal	O
,	O
is	O
controlled	O
by	O
the	O
eIF2alpha	B-GP
kinase	I-GP
IK2	B-GP
,	O
a	O
general	O
inhibitor	O
of	O
protein	O
synthesis	O
.	O

Whether	O
RNA	B-GP
-	I-GP
binding	I-GP
proteins	I-GP
participate	O
in	O
translational	O
regulation	O
in	O
sporozoites	O
remains	O
to	O
be	O
studied	O
.	O

Here	O
,	O
we	O
investigated	O
the	O
roles	O
of	O
two	O
RNA	B-GP
-	I-GP
binding	I-GP
proteins	I-GP
of	O
the	O
Puf	B-GP
-	O
family	O
,	O
Plasmodium	B-OG
Puf1	B-GP
and	O
Puf2	B-GP
,	O
during	O
sporozoite	O
stage	O
conversion	O
.	O

Our	O
data	O
reveal	O
that	O
,	O
in	O
the	O
rodent	B-OG
malaria	B-DS
parasite	O
P	B-OG
.	I-OG
berghei	I-OG
,	O
Puf2	B-GP
participates	O
in	O
the	O
regulation	O
of	O
IK2	B-GP
and	O
inhibits	O
premature	O
sporozoite	O
transformation	O
.	O

Inside	O
mosquito	B-OG
salivary	O
glands	O
puf2	B-GP
(-)	O
sporozoites	O
transform	O
over	O
time	O
to	O
round	O
forms	O
resembling	O
early	O
intra	O
-	O
hepatic	O
stages	O
.	O

As	O
a	O
result	O
,	O
mutant	O
parasites	O
display	O
strong	O
defects	O
in	O
initiating	O
a	O
malaria	B-DS
infection	B-DS
.	O

In	O
contrast	O
,	O
Puf1	B-GP
is	O
dispensable	O
in	O
vivo	O
throughout	O
the	O
entire	O
Plasmodium	B-OG
life	O
cycle	O
.	O

Our	O
findings	O
support	O
the	O
notion	O
of	O
a	O
central	O
role	O
for	O
Puf2	B-GP
in	O
parasite	O
latency	O
during	O
switch	O
between	O
the	O
insect	B-OG
and	O
mammalian	O
hosts	O
.	O

Introduction	O

Plasmodium	B-OG
parasites	O
,	O
the	O
causative	O
agents	O
of	O
malaria	B-DS
,	O
are	O
transmitted	O
by	O
female	O
Anopheles	B-OG
mosquitoes	B-OG
.	O

During	O
the	O
probing	O
phase	O
prior	O
to	O
the	O
blood	O
meal	O
,	O
sporozoites	O
are	O
injected	O
into	O
the	O
skin	O
of	O
the	O
mammalian	O
host	O
[	O
1	O
].	O

The	O
motile	O
sporozoites	O
actively	O
migrate	O
in	O
the	O
skin	O
,	O
enter	O
the	O
peripheral	O
blood	O
circulation	O
,	O
and	O
then	O
rapidly	O
reach	O
the	O
liver	O
.	O

Sporozoites	O
invade	O
hepatocytes	O
by	O
forming	O
a	O
parasitophorous	O
vacuole	O
(	O
PV	O
)	O
[	O
2	O
],	O
where	O
they	O
transform	O
into	O
replicative	O
exo	O
-	O
erythrocytic	O
forms	O
(	O
EEFs	O
).	O

After	O
intense	O
multiplication	O
during	O
2	O
–	O
6	O
days	O
,	O
depending	O
on	O
the	O
Plasmodium	B-OG
species	O
,	O
mature	O
EEFs	O
release	O
thousands	O
of	O
merozoites	O
,	O
which	O
invade	O
erythrocytes	O
and	O
initiate	O
the	O
pathogenic	O
blood	O
stage	O
cycle	O
[	O
3	O
].	O

Plasmodium	B-OG
sporozoites	O
are	O
formed	O
inside	O
oocysts	O
in	O
the	O
mosquito	B-OG
midgut	O
,	O
but	O
become	O
fully	O
infective	O
only	O
after	O
colonization	O
of	O
the	O
insect	B-OG
salivary	O
glands	O
.	O

This	O
maturation	O
process	O
is	O
associated	O
with	O
the	O
up	O
-	O
regulation	O
of	O
a	O
specific	O
subset	O
of	O
genes	O
,	O
referred	O
to	O
as	O
Up	B-GP
-	I-GP
regulated	I-GP
in	I-GP
Infective	I-GP
Sporozoites	I-GP
(	O
UIS	B-GP
)	O
genes	O
[	O
4	O
].	O

Regulation	O
of	O
gene	O
expression	O
in	O
Plasmodium	B-OG
remains	O
poorly	O
understood	O
.	O

Genome	O
sequencing	O
data	O
initially	O
revealed	O
a	O
paucity	O
of	O
specific	O
transcription	B-GP
factors	I-GP
in	O
Plasmodium	B-OG
[	O
5	O
].	O

Recently	O
however	O
,	O
a	O
family	O
of	O
genes	O
related	O
to	O
the	O
plant	B-OG
Apetala	B-GP
-	I-GP
2	I-GP
(	O
AP2	B-GP
)	O
transcription	B-GP
factors	I-GP
has	O
been	O
identified	O
in	O
Plasmodium	B-OG
and	O
related	O
apicomplexan	O
parasites	O
[	O
6	O
],	O
[	O
7	O
],	O
and	O
proposed	O
to	O
play	O
a	O
central	O
role	O
during	O
life	O
cycle	O
progression	O
.	O

Molecular	O
genetic	O
studies	O
have	O
demonstrated	O
vital	O
roles	O
of	O
two	O
stage	O
-	O
specific	O
AP2	B-GP
factors	O
in	O
Plasmodium	B-OG
berghei	I-OG
,	O
a	O
rodent	B-OG
malaria	B-DS
parasite	O
widely	O
used	O
as	O
a	O
model	O
[	O
8	O
],	O
[	O
9	O
].	O

One	O
of	O
these	O
factors	O
,	O
the	O
AP2	B-GP
-	O
Sp	B-GP
transcription	B-GP
factor	I-GP
,	O
is	O
required	O
during	O
sporozoite	O
differentiation	O
and	O
binds	O
to	O
a	O
specific	O
DNA	O
sequence	O
found	O
in	O
the	O
promoter	O
region	O
of	O
many	O
genes	O
expressed	O
in	O
sporozoites	O
,	O
including	O
,	O
but	O
not	O
restricted	O
to	O
,	O
UIS	B-GP
genes	O
[	O
8	O
].	O

Intriguingly	O
,	O
genes	O
containing	O
AP2	B-GP
-	O
Sp	B-GP
binding	O
sites	O
are	O
associated	O
with	O
a	O
wide	O
range	O
of	O
biological	O
processes	O
,	O
such	O
as	O
sporozoite	O
formation	O
,	O
host	O
cell	O
invasion	O
or	O
liver	O
stage	O
development	O
.	O

This	O
observation	O
strongly	O
suggests	O
that	O
additional	O
mechanisms	O
participate	O
in	O
the	O
fine	O
-	O
tuning	O
of	O
gene	O
expression	O
during	O
sporozoite	O
development	O
and	O
stage	O
conversion	O
.	O

Another	O
factor	O
,	O
called	O
SLARP	B-GP
or	O
SAP1	B-GP
,	O
controls	O
the	O
expression	O
of	O
a	O
subset	O
of	O
genes	O
in	O
sporozoites	O
,	O
and	O
plays	O
a	O
critical	O
role	O
during	O
intrahepatic	O
development	O
of	O
the	O
parasite	O
[	O
10	O
],	O
[	O
11	O
].	O

It	O
is	O
still	O
unclear	O
whether	O
SLARP	B-GP
/	O
SAP1	B-GP
acts	O
on	O
a	O
transcriptional	O
or	O
a	O
post	O
-	O
transcriptional	O
level	O
.	O

The	O
cellular	O
localization	O
of	O
SLARP	B-GP
/	O
SAP1	B-GP
remains	O
controversial	O
[	O
10	O
],	O
[	O
11	O
],	O
and	O
the	O
absence	O
of	O
any	O
domain	O
known	O
to	O
bind	O
nucleic	O
acids	O
suggests	O
an	O
indirect	O
role	O
.	O

More	O
recently	O
,	O
Zhang	O
and	O
colleagues	O
reported	O
that	O
the	O
protein	B-GP
kinase	I-GP
IK2	B-GP
,	O
initially	O
termed	O
UIS1	B-GP
[	O
4	O
],	O
controls	O
global	O
gene	O
expression	O
in	O
sporozoites	O
at	O
a	O
post	O
-	O
transcriptional	O
level	O
[	O
12	O
].	O

IK2	B-GP
phosphorylates	O
the	O
translation	B-GP
initiation	I-GP
factor	I-GP
eIF2alpha	B-GP
and	O
down	O
-	O
regulates	O
protein	O
synthesis	O
[	O
12	O
],	O
[	O
13	O
].	O
P	B-OG
.	I-OG
berghei	I-OG
lacking	O
UIS1	B-GP
/	O
IK2	B-GP
display	O
a	O
partial	O
loss	O
of	O
infectivity	O
associated	O
with	O
premature	O
transformation	O
of	O
sporozoites	O
in	O
the	O
mosquito	B-OG
salivary	O
glands	O
[	O
12	O
].	O

The	O
contribution	O
of	O
RNA	B-GP
-	I-GP
binding	I-GP
prxoteins	I-GP
in	O
translational	O
regulation	O
has	O
not	O
been	O
studied	O
in	O
sporozoites	O
yet	O
,	O
but	O
has	O
been	O
well	O
characterized	O
in	O
Plasmodium	B-OG
sexual	O
stages	O
.	O

In	O
female	O
gametocytes	O
,	O
many	O
transcripts	O
encoding	O
ookinete	B-GP
proteins	I-GP
are	O
translationally	O
repressed	O
by	O
a	O
DEAD	B-GP
-	I-GP
box	I-GP
RNA	I-GP
helicase	I-GP
called	O
DOZI	B-GP
,	O
which	O
binds	O
to	O
the	O
3	O
′	O
untranslated	O
region	O
(	O
UTR	O
)	O
of	O
target	O
mRNAs	O
such	O
as	O
P28	B-GP
and	O
blocks	O
their	O
translation	O
until	O
occurrence	O
of	O
gamete	O
fertilization	O
and	O
differentiation	O
into	O
a	O
zygote	O
and	O
ookinete	O
[	O
14	O
],	O
[	O
15	O
].	O

Whether	O
DOZI	B-GP
plays	O
a	O
role	O
in	O
sporozoites	O
is	O
not	O
known	O
,	O
but	O
other	O
RNA	B-GP
-	I-GP
binding	I-GP
proteins	I-GP
may	O
participate	O
in	O
translational	O
regulation	O
in	O
sporozoites	O
,	O
including	O
members	O
of	O
the	O
Puf	B-GP
-	O
family	O
.	O

Puf	B-GP
proteins	O
are	O
evolutionary	O
conserved	O
in	O
eukaryotes	B-OG
and	O
are	O
characterized	O
by	O
the	O
presence	O
of	O
a	O
RNA	O
-	O
binding	O
Puf	B-GP
domain	O
,	O
named	O
after	O
the	O
Drosophila	B-OG
melanogaster	I-OG
protein	O
Pumilio	B-GP
and	O
the	O
Caenorhabditis	B-OG
elegans	I-OG
protein	O
fem	B-GP
-	I-GP
3	I-GP
binding	I-GP
factor	I-GP
(	O
FBF	B-GP
),	O
and	O
consisting	O
of	O
eight	O
imperfect	O
repeats	O
of	O
36	O
amino	O
acids	O
(	O
PFAM	O
:	O
PF00806	O
)	O
[	O
16	O
],	O
[	O
17	O
].	O

Puf	B-GP
proteins	O
typically	O
bind	O
to	O
the	O
3	O
′	O
UTR	O
of	O
target	O
mRNAs	O
and	O
repress	O
their	O
translation	O
or	O
induce	O
their	O
degradation	O
(	O
reviewed	O
in	O
[	O
18	O
]	O
and	O
[	O
19	O
]).	O
Plasmodium	B-OG
parasites	O
possess	O
two	O
genes	O
encoding	O
proteins	O
with	O
Puf	B-GP
domains	O
,	O
Puf1	B-GP
and	O
Puf2	B-GP
[	O
20	O
].	O

In	O
P	B-OG
.	I-OG
falciparum	I-OG
,	O
both	O
Puf1	B-GP
(	O
PFE0935c	O
)	O
and	O
Puf2	B-GP
(	O
PFD0825c	O
)	O
are	O
differentially	O
expressed	O
in	O
gametocytes	O
[	O
20	O
],	O
[	O
21	O
].	O

Targeted	O
gene	O
disruption	O
in	O
P	B-OG
.	I-OG
falciparum	I-OG
recently	O
revealed	O
a	O
role	O
of	O
PfPuf2	B-GP
in	O
repressing	O
gametocytogenesis	O
and	O
male	O
gametocyte	O
differentiation	O
in	O
the	O
human	B-OG
malaria	B-DS
parasite	O
[	O
22	O
].	O

Whether	O
the	O
Puf2	B-GP
protein	O
plays	O
additional	O
,	O
perhaps	O
vital	O
,	O
roles	O
in	O
subsequent	O
life	O
cycle	O
stages	O
remains	O
to	O
be	O
shown	O
.	O

Interestingly	O
,	O
microarray	O
data	O
indicate	O
that	O
Puf2	B-GP
is	O
most	O
highly	O
expressed	O
in	O
P	B-OG
.	I-OG
falciparum	I-OG
sporozoites	O
[	O
23	O
],	O
and	O
in	O
P	B-OG
.	I-OG
berghei	I-OG
,	O
expression	O
of	O
both	O
Puf1	B-GP
(	O
PBANKA_123350	O
)	O
and	O
Puf2	B-GP
(	O
PBANKA_071920	O
)	O
has	O
been	O
reported	O
in	O
sporozoites	O
,	O
where	O
Puf1	B-GP
was	O
initially	O
identified	O
as	O
UIS9	B-GP
[	O
4	O
],	O
[	O
24	O
].	O

In	O
this	O
study	O
,	O
we	O
used	O
a	O
reverse	O
genetic	O
approach	O
to	O
investigate	O
the	O
roles	O
of	O
Puf1	B-GP
and	O
Puf2	B-GP
in	O
P	B-OG
.	I-OG
berghei	I-OG
,	O
with	O
the	O
aim	O
to	O
identify	O
potential	O
mRNA	O
binding	O
proteins	O
that	O
play	O
critical	O
roles	O
in	O
sporozoite	O
stage	O
conversion	O
.	O

Results	O

Targeted	O
gene	O
deletion	O
of	O
P	B-OG
.	I-OG
berghei	I-OG
Puf1	B-GP
and	O
Puf2	B-GP

We	O
first	O
assessed	O
the	O
expression	O
of	O
Puf1	B-GP
and	O
Puf2	B-GP
during	O
P	B-OG
.	I-OG
berghei	I-OG
development	O
in	O
the	O
insect	B-OG
vector	O
,	O
in	O
comparison	O
to	O
DOZI	B-GP
and	O
UIS1	B-GP
/	O
IK2	B-GP
,	O
using	O
quantitative	O
RT	O
-	O
PCR	O
(	O
Figure	O
1	O
).	O

Similarly	O
to	O
UIS1	B-GP
/	O
IK2	B-GP
[	O
12	O
],	O
we	O
found	O
that	O
Puf1	B-GP
and	O
Puf2	B-GP
are	O
upregulated	O
in	O
P	B-OG
.	I-OG
berghei	I-OG
salivary	O
gland	O
sporozoites	O
(	O
Figure	O
1	O
).	O

This	O
was	O
expected	O
for	O
Puf1	B-GP
,	O
which	O
was	O
initially	O
described	O
as	O
UIS9	B-GP
[	O
4	O
],	O
[	O
24	O
].	O

Furthermore	O
,	O
Puf1	B-GP
was	O
also	O
upregulated	O
in	O
gametocytes	O
and	O
ookinetes	O
,	O
similarly	O
to	O
IK2	B-GP
and	O
DOZI	B-GP
.	O

In	O
good	O
agreement	O
with	O
published	O
microarray	O
data	O
[	O
24	O
],	O
only	O
low	O
levels	O
of	O
DOZI	B-GP
mRNA	O
were	O
detected	O
in	O
P	B-OG
.	I-OG
berghei	I-OG
sporozoites	O
(	O
Figure	O
1	O
).	O

In	O
contrast	O
to	O
Puf1	B-GP
and	O
Puf2	B-GP
,	O
DOZI	B-GP
steady	O
state	O
mRNA	O
levels	O
were	O
down	O
-	O
regulated	O
in	O
infectious	O
salivary	O
gland	O
-	O
associated	O
sporozoites	O
resulting	O
in	O
∼	O
100	O
fold	O
lower	O
levels	O
in	O
the	O
latent	O
transmission	O
stage	O
.	O

Together	O
,	O
the	O
expression	O
profiling	O
indicated	O
that	O
both	O
Puf	B-GP
members	O
could	O
play	O
a	O
role	O
in	O
sporozoite	O
stage	O
conversion	O
,	O
as	O
has	O
been	O
described	O
previously	O
for	O
the	O
eIF2alpha	B-GP
kinase	I-GP
UIS1	B-GP
/	O
IK2	B-GP
[	O
12	O
].	O

Puf1	B-GP
and	O
Puf2	B-GP
are	O
upregulated	O
in	O
P	B-OG
.	I-OG
berghei	I-OG
sporozoites	O
.	O

Shown	O
is	O
an	O
expression	O
profiling	O
of	O
selected	O
transcripts	O
of	O
RNA	O
regulatory	B-GP
proteins	I-GP
,	O
the	O
DDX6	B-GP
-	O
family	O
DEAD	B-GP
-	I-GP
box	I-GP
helicase	I-GP
DOZI	B-GP
[	O
15	O
],	O
the	O
Puf	B-GP
proteins	O
Puf1	B-GP
and	O
Puf2	B-GP
[	O
20	O
],	O
and	O
of	O
the	O
eIF2alpha	B-GP
kinase	I-GP
UIS1	B-GP
/	O
IK2	B-GP
that	O
controls	O
sporozoite	O
latency	O
[	O
12	O
].	O
P	B-OG
.	I-OG
berghei	I-OG
purified	O
gametocytes	O
,	O
ookinetes	O
,	O
oocysts	O
and	O
salivary	O
gland	O
sporozoites	O
were	O
analyzed	O
by	O
RT	O
-	O
qPCR	O
using	O
primers	O
specific	O
for	O
DOZI	B-GP
,	O
UIS1	B-GP
/	O
IK2	B-GP
,	O
Puf1	B-GP
and	O
Puf2	B-GP
.	O

Expression	O
data	O
from	O
two	O
independent	O
experiments	O
are	O
shown	O
and	O
were	O
normalized	O
to	O
the	O
level	O
of	O
GFP	B-GP
transcripts	O
,	O
which	O
are	O
expressed	O
under	O
the	O
control	O
of	O
the	O
EF1alpha	B-GP
promoter	O
[	O
26	O
].	O

In	O
order	O
to	O
investigate	O
the	O
functional	O
importance	O
of	O
Puf1	B-GP
/	O
UIS9	B-GP
and	O
Puf2	B-GP
in	O
P	B-OG
.	I-OG
berghei	I-OG
,	O
we	O
generated	O
loss	O
-	O
of	O
-	O
function	O
mutants	O
(	O
Figure	O
2	O
).	O

We	O
used	O
a	O
replacement	O
strategy	O
to	O
disrupt	O
the	O
endogenous	O
Puf1	B-GP
(	O
Figure	O
2A	O
)	O
or	O
Puf2	B-GP
(	O
Figure	O
2B	O
)	O
gene	O
copy	O
by	O
double	O
crossover	O
homologous	O
recombination	O
[	O
25	O
].	O

Targeting	O
constructs	O
containing	O
5	O
′	O
and	O
3	O
′	O
fragments	O
of	O
either	O
Puf1	B-GP
or	O
Puf2	B-GP
flanking	O
a	O
pyrimethamine	O
-	O
resistance	O
cassette	O
were	O
used	O
to	O
transfect	O
P	B-OG
.	I-OG
berghei	I-OG
parasites	O
that	O
constitutively	O
express	O
GFP	B-GP
(	O
ANKA	O
cl507	O
)	O
[	O
26	O
].	O

Recombinant	O
parasites	O
were	O
selected	O
with	O
pyrimethamine	O
in	O
the	O
mouse	B-OG
drinking	O
water	O
,	O
and	O
cloned	O
by	O
limiting	O
dilutions	O
.	O

For	O
both	O
genes	O
we	O
were	O
successful	O
in	O
generating	O
clonal	O
knockout	O
parasite	O
populations	O
,	O
as	O
demonstrated	O
by	O
PCR	O
and	O
Southern	O
blot	O
analysis	O
of	O
genomic	O
DNA	O
(	O
Figures	O
2C	O
–	O
F	O
).	O

For	O
Puf2	B-GP
we	O
also	O
generated	O
a	O
second	O
independent	O
knockout	O
clone	O
,	O
which	O
was	O
phenotypically	O
identical	O
to	O
the	O
first	O
puf2	B-GP
(-)	O
clonal	O
parasite	O
line	O
(	O
unpublished	O
data	O
).	O

This	O
indicates	O
that	O
Puf1	B-GP
and	O
Puf2	B-GP
do	O
not	O
play	O
any	O
vital	O
role	O
during	O
P	B-OG
.	I-OG
berghei	I-OG
erythrocytic	O
stages	O
,	O
in	O
good	O
agreement	O
with	O
successful	O
generation	O
of	O
Pfpuf2	B-GP
(-)	O
parasites	O
[	O
22	O
].	O

Targeted	O
gene	O
deletion	O
of	O
Puf1	B-GP
/	O
UIS9	B-GP
and	O
Puf2	B-GP
in	O
P	B-OG
.	I-OG
berghei	I-OG
.	O

(	O
A	O
–	O
B	O
)	O
Replacement	O
strategy	O
to	O
generate	O
the	O
puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
parasites	O
.	O
P	B-OG
.	I-OG
berghei	I-OG
PUF1	B-GP
gene	O
(	O
A	O
)	O
consists	O
of	O
five	O
exons	O
encoding	O
an	O
1183	O
amino	O
-	O
acid	O
protein	O
(	O
PBANKA_123350	O
),	O
whereas	O
PUF2	B-GP
(	O
B	O
)	O
consists	O
of	O
four	O
exons	O
encoding	O
a	O
477	O
amino	O
-	O
acid	O
protein	O
(	O
PBANKA_071920	O
).	O

The	O
PUF	B-GP
domains	O
are	O
shown	O
in	O
blue	O
.	O

For	O
each	O
gene	O
,	O
the	O
wild	O
-	O
type	O
(	O
WT	O
)	O
genomic	O
locus	O
was	O
targeted	O
with	O
a	O
replacement	O
plasmid	O
containing	O
5	O
′	O
and	O
3	O
′	O
regions	O
of	O
PUF1	B-GP
or	O
PUF2	B-GP
and	O
a	O
positive	O
selectable	O
marker	O
,	O
Toxoplasma	B-OG
gondii	I-OG
dhfr	B-GP
/	O
ts	B-GP
or	O
human	B-OG
DHFR	B-GP
,	O
respectively	O
.	O

Upon	O
a	O
double	O
crossover	O
event	O
,	O
the	O
PUF1	B-GP
or	O
PUF2	B-GP
gene	O
is	O
replaced	O
by	O
the	O
selectable	O
marker	O
.	O

Replacement	O
-	O
and	O
wild	O
type	O
-	O
specific	O
test	O
primer	O
combinations	O
and	O
expected	O
PCR	O
fragments	O
(	O
WT	O
,	O
5	O
′	O
integration	O
and	O
3	O
′	O
integration	O
)	O
are	O
indicated	O
by	O
arrows	O
and	O
lines	O
,	O
respectively	O
.	O

Restriction	O
sites	O
,	O
Southern	O
probes	O
and	O
expected	O
restriction	O
fragments	O
are	O
also	O
shown	O
.	O
S	O
,	O
SpeI	B-GP
;	O
X	O
,	O
XhoI	B-GP
;	O
A	O
,	O
AfeI	B-GP
;	O
E	O
,	O
EcoRV	B-GP
.	O

(	O
C	O
)	O
Puf1	B-GP
replacement	O
-	O
specific	O
PCR	O
analysis	O
.	O

Confirmation	O
of	O
the	O
predicted	O
gene	O
targeting	O
is	O
achieved	O
by	O
specific	O
primer	O
combinations	O
(	O
5	O
′	O
and	O
3	O
′	O
integration	O
),	O
which	O
can	O
only	O
amplify	O
a	O
signal	O
from	O
the	O
recombinant	O
locus	O
.	O

A	O
wild	O
type	O
-	O
specific	O
PCR	O
reaction	O
confirms	O
the	O
absence	O
of	O
residual	O
wild	O
-	O
type	O
parasites	O
in	O
the	O
clonal	O
puf1	B-GP
(-)	O
population	O
.	O

(	O
D	O
)	O
Southern	O
blot	O
analysis	O
of	O
genomic	O
DNA	O
isolated	O
from	O
WT	O
,	O
puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
parasites	O
,	O
using	O
digoxigenin	O
-	O
labelled	O
probes	O
specific	O
for	O
Puf1	B-GP
.	O

After	O
digest	O
with	O
SpeI	B-GP
and	O
XhoI	B-GP
,	O
the	O
Puf1	B-GP
probe	O
hybridizes	O
to	O
a	O
8	O
.	O
3	O
or	O
a	O
6	O
.	O
9	O
kb	O
fragment	O
in	O
WT	O
and	O
puf1	B-GP
(-)	O
parasites	O
,	O
respectively	O
.	O

(	O
E	O
)	O
Puf2	B-GP
replacement	O
-	O
specific	O
PCR	O
analysis	O
.	O

Confirmation	O
of	O
the	O
predicted	O
gene	O
targeting	O
is	O
achieved	O
by	O
specific	O
primer	O
combinations	O
(	O
5	O
′	O
and	O
3	O
′	O
integration	O
),	O
which	O
can	O
only	O
amplify	O
a	O
signal	O
from	O
the	O
recombinant	O
locus	O
.	O

A	O
wild	O
type	O
-	O
specific	O
PCR	O
reaction	O
confirms	O
the	O
absence	O
of	O
residual	O
wild	O
-	O
type	O
parasites	O
in	O
the	O
clonal	O
puf2	B-GP
(-)	O
population	O
.	O

(	O
F	O
)	O
Southern	O
blot	O
analysis	O
of	O
genomic	O
DNA	O
isolated	O
from	O
WT	O
,	O
puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
parasites	O
,	O
using	O
digoxigenin	O
-	O
labelled	O
probes	O
specific	O
for	O
Puf2	B-GP
.	O

After	O
digest	O
with	O
AfeI	B-GP
and	O
EcoRV	B-GP
,	O
the	O
Puf2	B-GP
probe	O
hybridizes	O
to	O
a	O
8	O
.	O
4	O
kb	O
fragment	O
in	O
WT	O
and	O
a	O
4	O
.	O
0	O
kb	O
fragment	O
in	O
puf2	B-GP
(-)	O
parasites	O
.	O

puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
parasites	O
produce	O
gametocytes	O
that	O
develop	O
to	O
sporozoites	O
in	O
mosquitoes	B-OG

puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
parasites	O
were	O
indistinguishable	O
from	O
WT	O
parasites	O
in	O
development	O
and	O
growth	O
of	O
asexual	O
blood	O
stages	O
and	O
produced	O
gametocytes	O
.	O

Because	O
PfPuf2	B-GP
has	O
been	O
shown	O
to	O
control	O
gametocytogenesis	O
in	O
P	B-OG
.	I-OG
falciparum	I-OG
[	O
22	O
],	O
we	O
analyzed	O
in	O
more	O
detail	O
the	O
sexual	O
development	O
of	O
P	B-OG
.	I-OG
berghei	I-OG
puf2	B-GP
(-)	O
parasites	O
.	O

After	O
injection	O
of	O
107	O
infected	O
erythrocytes	O
intravenously	O
into	O
groups	O
of	O
five	O
C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
,	O
parasitemia	B-DS
at	O
day	O
4	O
were	O
similar	O
in	O
mice	B-OG
infected	O
with	O
WT	O
or	O
puf2	B-GP
(-)	O
(	O
Figure	O
3A	O
).	O

However	O
,	O
the	O
proportion	O
of	O
gametocytes	O
among	O
all	O
parasite	O
stages	O
was	O
significantly	O
higher	O
in	O
puf2	B-GP
(-)	O
than	O
in	O
WT	O
parasites	O
(	O
Figure	O
3B	O
).	O

We	O
then	O
examined	O
the	O
ability	O
of	O
mature	O
male	O
gametocytes	O
to	O
exflagellate	O
in	O
puf2	B-GP
(-)	O
parasites	O
.	O

The	O
number	O
of	O
exflagellation	O
centers	O
in	O
mouse	B-OG
blood	O
was	O
significantly	O
higher	O
for	O
puf2	B-GP
(-)	O
parasites	O
than	O
for	O
WT	O
parasites	O
(	O
Figure	O
3C	O
),	O
suggesting	O
that	O
male	O
gametocytes	O
contribute	O
to	O
the	O
increased	O
gametocytogenesis	O
in	O
Pbpuf2	B-GP
(-)	O
parasites	O
,	O
in	O
full	O
support	O
of	O
the	O
data	O
reported	O
for	O
P	B-OG
.	I-OG
falciparum	I-OG
Puf2	B-GP
-	O
deficient	O
parasites	O
[	O
22	O
].	O

Gametocytogenesis	O
is	O
increased	O
in	O
puf2	B-GP
(-)	O
parasites	O
.	O

Groups	O
of	O
C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
(	O
n	O
=	O
5	O
)	O
were	O
injected	O
intravenously	O
with	O
107	O
WT	O
or	O
puf2	B-GP
(-)	O
infected	O
erythrocytes	O
.	O

Blood	O
was	O
collected	O
from	O
the	O
mice	B-OG
4	O
days	O
later	O
to	O
determine	O
the	O
parasitemia	B-DS
(	O
A	O
),	O
the	O
proportion	O
of	O
gametocytes	O
among	O
parasites	O
(	O
B	O
),	O
and	O
the	O
number	O
of	O
exflagellation	O
centers	O
per	O
µl	O
of	O
blood	O
(	O
C	O
).	O
Results	O
are	O
expressed	O
as	O
mean	O
+/−	O
SEM	O
.	O
**,	O
p	O
<	O
0	O
.	O
01	O
(	O
Mann	O
-	O
Whitney	O
test	O
).	O

After	O
transmission	O
to	O
Anopheles	B-OG
stephensi	I-OG
mosquitoes	B-OG
,	O
both	O
puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
parasite	O
lines	O
produced	O
oocysts	O
and	O
high	O
numbers	O
of	O
sporozoites	O
(	O
Table	O
1	O
).	O

The	O
number	O
of	O
puf2	B-GP
(-)	O
oocysts	O
was	O
significantly	O
higher	O
than	O
for	O
WT	O
,	O
consistent	O
with	O
the	O
higher	O
gametocyte	O
rates	O
.	O

Intriguingly	O
,	O
we	O
found	O
lower	O
numbers	O
of	O
oocysts	O
and	O
salivary	O
gland	O
sporozoites	O
in	O
puf1	B-GP
(-)-	O
infected	O
mosquitoes	B-OG
,	O
as	O
compared	O
to	O
WT	O
parasites	O
(	O
Table	O
1	O
).	O

Although	O
the	O
differences	O
were	O
not	O
statistically	O
significant	O
,	O
we	O
cannot	O
exclude	O
an	O
effect	O
of	O
puf1	B-GP
depletion	O
on	O
oocyst	O
development	O
and	O
sporogony	O
.	O

Loss	O
of	O
infectivity	O
of	O
puf2	B-GP
(-)	O
sporozoites	O
in	O
C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
.	O

Parasites	O

Number	O
of	O
oocysts	O
/	O
mosquitoa	O
(	O
mean	O
±	O
SD	O
)	O

Number	O
of	O
salivary	O
gland	O
sporozoites	O
/	O
mosquitoa	O
(	O
mean	O
±	O
SD	O
)	O

Route	O
of	O
injectionb	O

Number	O
of	O
infected	O
/	O
Number	O
of	O
injected	O

Prepatency	O
period	O
(	O
days	O
)	O
c	O

WT	O

182	O
(±	O
164	O
)	O

31	O
,	O
600	O
(±	O
18	O
,	O
600	O
)	O

bites	O
(	O
d	O
21	O
)	O

3	O
/	O
3	O

3	O

i	O
.	O
v	O
.	O

(	O
d	O
18	O
)	O

2	O
/	O
2	O

3	O

i	O
.	O
v	O
.	O

(	O
d	O
21	O
)	O

6	O
/	O
6	O

3	O
.	O
5	O

i	O
.	O
v	O
.	O

(	O
d	O
25	O
)	O

4	O
/	O
4	O

3	O

puf1	B-GP
(-)	O

137	O
(±	O
100	O
)	O

11	O
,	O
400	O
(±	O
4	O
,	O
700	O
)	O

bites	O
(	O
d	O
17	O
)	O

3	O
/	O
3	O

3	O

i	O
.	O
v	O
.	O

(	O
d	O
21	O
)	O

6	O
/	O
6	O

3	O
.	O
5	O

puf2	B-GP
(-)	O

320	O
(±	O
234	O
)	O
d	O

25	O
,	O
000	O
(±	O
18	O
,	O
800	O
)	O

bites	O
(	O
d	O
21	O
)	O

3	O
/	O
4	O

(	O
5	O
)	O

i	O
.	O
v	O
.	O

(	O
d	O
18	O
)	O

2	O
/	O
4	O

(	O
5	O
)	O

i	O
.	O
v	O
.	O

(	O
d	O
25	O
)	O

0	O
/	O
4	O

NA	O

The	O
number	O
of	O
midgut	O
oocysts	O
and	O
salivary	O
gland	O
sporozoites	O
was	O
determined	O
at	O
d10	O
–	O
14	O
and	O
d18	O
–	O
25	O
,	O
respectively	O
,	O
after	O
the	O
infectious	O
blood	O
meal	O
,	O
from	O
at	O
least	O
three	O
independent	O
feeding	O
experiments	O
.	O

C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
were	O
exposed	O
to	O
the	O
bites	O
of	O
10	O
infected	O
mosquitoes	B-OG
or	O
injected	O
intravenously	O
(	O
i	O
.	O
v	O
.)	O
with	O
1	O
,	O
000	O
sporozoites	O
,	O
18	O
–	O
25	O
days	O
after	O
mosquito	B-OG
infection	B-DS
.	O

The	O
prepatent	O
period	O
is	O
defined	O
as	O
the	O
number	O
of	O
days	O
after	O
sporozoite	O
inoculation	O
until	O
detection	O
of	O
infected	O
erythrocytes	O
by	O
microscopic	O
blood	O
smear	O
examination	O
.	O

Brackets	O
indicate	O
that	O
not	O
all	O
animals	B-OG
became	O
infected	O
.	O

NA	O
,	O
not	O
applicable	O
.	O

p	O
<	O
0	O
.	O
05	O
in	O
comparison	O
to	O
WT	O
,	O
as	O
determined	O
by	O
Kruskal	O
-	O
Wallis	O
followed	O
by	O
Dunn	O
'	O
s	O
test	O
.	O

Liver	B-DS
infection	I-DS
is	O
impaired	O
in	O
Puf2	B-GP
-	O
deficient	O
parasites	O

We	O
then	O
analysed	O
the	O
infectivity	O
of	O
puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
sporozoites	O
to	O
susceptible	O
mice	B-OG
.	O

C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
were	O
injected	O
intravenously	O
with	O
1	O
,	O
000	O
WT	O
,	O
puf1	B-GP
(-)	O
or	O
puf2	B-GP
(-)	O
P	B-OG
.	I-OG
berghei	I-OG
sporozoites	O
,	O
or	O
exposed	O
to	O
the	O
bites	O
of	O
10	O
infected	O
mosquitoes	B-OG
,	O
the	O
natural	O
transmission	O
route	O
(	O
Table	O
1	O
).	O

Emergence	O
of	O
erythrocytic	O
stages	O
,	O
resulting	O
from	O
complete	O
liver	O
stage	O
development	O
,	O
was	O
monitored	O
by	O
microscopic	O
examination	O
of	O
daily	O
blood	O
smears	O
.	O

With	O
both	O
inoculation	O
routes	O
,	O
all	O
mice	B-OG
injected	O
with	O
puf1	B-GP
(-)	O
sporozoites	O
developed	O
a	O
parasitemia	B-DS
,	O
with	O
no	O
delay	O
as	O
compared	O
to	O
WT	O
parasites	O
(	O
Table	O
1	O
).	O

In	O
contrast	O
,	O
only	O
a	O
fraction	O
of	O
the	O
mice	B-OG
injected	O
with	O
puf2	B-GP
(-)	O
sporozoites	O
developed	O
a	O
parasitemia	B-DS
,	O
with	O
a	O
two	O
-	O
day	O
delay	O
as	O
compared	O
to	O
WT	O
,	O
indicative	O
of	O
at	O
least	O
100	O
-	O
fold	O
reduction	O
of	O
infectivity	O
(	O
Table	O
1	O
).	O

Moreover	O
,	O
puf2	B-GP
(-)	O
sporozoites	O
isolated	O
late	O
after	O
mosquito	B-OG
infection	B-DS
(	O
at	O
day	O
25	O
)	O
were	O
not	O
capable	O
of	O
inducing	O
a	O
blood	O
stage	O
infection	B-DS
in	O
mice	B-OG
.	O

We	O
next	O
injected	O
C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
intravenously	O
with	O
WT	O
,	O
puf1	B-GP
(-)	O
or	O
puf2	B-GP
(-)	O
sporozoites	O
isolated	O
on	O
day	O
18	O
from	O
mosquito	B-OG
salivary	O
glands	O
.	O

Forty	O
-	O
two	O
hours	O
after	O
infection	B-DS
,	O
livers	O
were	O
removed	O
and	O
the	O
parasite	O
loads	O
were	O
quantified	O
by	O
RT	O
-	O
qPCR	O
.	O

As	O
shown	O
in	O
Figure	O
4	O
,	O
the	O
puf2	B-GP
(-)	O
liver	O
loads	O
were	O
extremely	O
reduced	O
(∼	O
500	O
fold	O
)	O
as	O
compared	O
to	O
WT	O
,	O
confirming	O
that	O
infectivity	O
of	O
puf2	B-GP
(-)	O
sporozoites	O
to	O
C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
is	O
severely	O
impaired	O
.	O

The	O
reduction	O
of	O
parasite	O
liver	O
loads	O
as	O
measured	O
by	O
RT	O
-	O
qPCR	O
is	O
consistent	O
with	O
the	O
delay	O
or	O
absence	O
of	O
parasitemia	B-DS
in	O
mice	B-OG
injected	O
with	O
puf2	B-GP
(-)	O
sporozoites	O
(	O
Table	O
1	O
),	O
therefore	O
we	O
assume	O
that	O
the	O
absence	O
of	O
Puf2	B-GP
did	O
not	O
interfere	O
with	O
18S	O
rRNA	O
quantification	O
.	O

Interestingly	O
,	O
we	O
also	O
observed	O
a	O
significant	O
,	O
although	O
less	O
pronounced	O
(∼	O
4	O
fold	O
),	O
reduction	O
of	O
puf1	B-GP
(-)	O
parasite	O
liver	O
loads	O
(	O
Figure	O
4	O
).	O

Our	O
findings	O
demonstrate	O
that	O
PbPuf2	B-GP
plays	O
an	O
important	O
in	O
vivo	O
role	O
only	O
in	O
the	O
pre	O
-	O
erythrocytic	O
phase	O
of	O
the	O
Plasmodium	B-OG
life	O
cycle	O
.	O

In	O
contrast	O
,	O
Puf1	B-GP
/	O
UIS9	B-GP
appears	O
to	O
be	O
dispensable	O
for	O
parasite	O
life	O
cycle	O
progression	O
,	O
at	O
least	O
under	O
the	O
conditions	O
tested	O
.	O

Liver	B-DS
infection	I-DS
is	O
severely	O
impaired	O
in	O
puf2	B-GP
(-)	O
parasites	O
.	O

Parasite	O
loads	O
were	O
determined	O
by	O
RT	O
-	O
qPCR	O
analysis	O
of	O
mouse	B-OG
livers	O
(	O
n	O
=	O
4	O
or	O
5	O
per	O
group	O
)	O
harvested	O
42	O
hours	O
after	O
intravenous	O
injection	O
of	O
10	O
,	O
000	O
WT	O
,	O
puf1	B-GP
(-)	O
or	O
puf2	B-GP
(-)	O
sporozoites	O
.	O

Results	O
are	O
expressed	O
as	O
the	O
relative	O
expression	O
of	O
Pb18S	O
normalized	O
to	O
mouse	B-OG
GAPDH	B-GP
.	O

The	O
means	O
+/−	O
SEM	O
are	O
indicated	O
by	O
lines	O
**,	O
p	O
<	O
0	O
.	O
01	O
(	O
Mann	O
-	O
Whitney	O
test	O
).	O

We	O
also	O
determined	O
the	O
In	O
vitro	O
infectivity	O
of	O
puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
sporozoites	O
isolated	O
on	O
day	O
22	O
from	O
mosquito	B-OG
salivary	O
glands	O
,	O
in	O
cultured	O
HepG2	O
hepatoma	B-DS
cells	O
(	O
Figure	O
5	O
).	O

Both	O
puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
sporozoites	O
entered	O
hepatoma	B-DS
cells	O
as	O
efficiently	O
as	O
WT	O
,	O
as	O
evidenced	O
by	O
similar	O
numbers	O
of	O
infected	O
cells	O
at	O
early	O
time	O
points	O
(	O
4	O
–	O
6	O
hours	O
)	O
(	O
Figure	O
5A	O
).	O

While	O
the	O
number	O
of	O
EEFs	O
at	O
later	O
time	O
points	O
(	O
24	O
–	O
48	O
hours	O
)	O
was	O
similar	O
in	O
WT	O
-	O
and	O
puf1	B-GP
(-)-	O
infected	O
cultures	O
(	O
Figure	O
5A	O
),	O
it	O
was	O
reduced	O
in	O
the	O
case	O
of	O
puf2	B-GP
(-)	O
parasites	O
(	O
Figure	O
5B	O
).	O

Whereas	O
early	O
after	O
infection	B-DS
a	O
vast	O
majority	O
(	O
81	O
%	O
±	O
3	O
%;	O
n	O
=	O
122	O
)	O
of	O
intracellular	O
WT	O
sporozoites	O
expressed	O
UIS4	B-GP
,	O
a	O
transmembrane	B-GP
protein	I-GP
that	O
localizes	O
to	O
the	O
membrane	O
of	O
the	O
PV	O
[	O
27	O
],	O
only	O
half	O
of	O
puf2	B-GP
(-)	O
parasites	O
were	O
stained	O
with	O
UIS4	B-GP
antibodies	B-GP
(	O
53	O
%	O
±	O
9	O
%;	O
n	O
=	O
127	O
).	O

This	O
indicates	O
that	O
a	O
substantial	O
fraction	O
of	O
puf2	B-GP
(-)	O
sporozoites	O
failed	O
to	O
form	O
and	O
/	O
or	O
remodel	O
the	O
PV	O
in	O
vitro	O
,	O
which	O
probably	O
explains	O
the	O
reduced	O
EEF	O
numbers	O
quantified	O
at	O
later	O
time	O
points	O
.	O

In	O
addition	O
,	O
we	O
cannot	O
exclude	O
a	O
moderate	O
impairment	O
during	O
liver	O
stage	O
development	O
in	O
puf2	B-GP
(-)	O
parasites	O
,	O
as	O
suggested	O
by	O
the	O
reduction	O
of	O
EEF	O
numbers	O
observed	O
between	O
24	O
and	O
48	O
hours	O
post	O
-	O
infection	B-DS
in	O
vitro	O
.	O

Nevertheless	O
,	O
most	O
puf2	B-GP
(-)	O
sporozoites	O
that	O
formed	O
a	O
PV	O
and	O
expressed	O
UIS4	B-GP
were	O
capable	O
of	O
developing	O
into	O
EEFs	O
like	O
WT	O
and	O
puf1	B-GP
(-)	O
parasites	O
(	O
Figure	O
5C	O
).	O

Taken	O
together	O
,	O
our	O
data	O
indicate	O
that	O
Puf2	B-GP
plays	O
a	O
critical	O
role	O
during	O
transmission	O
of	O
P	B-OG
.	I-OG
berghei	I-OG
sporozoites	O
to	O
the	O
mammalian	O
host	O
,	O
but	O
is	O
not	O
required	O
for	O
liver	O
stage	O
development	O
per	O
se	O
.	O

puf2	B-GP
(-)	O
sporozoites	O
are	O
infective	O
in	O
vitro	O
.	O

(	O
A	O
)	O
HepG2	O
cells	O
were	O
infected	O
with	O
WT	O
or	O
puf1	B-GP
(-)	O
sporozoites	O
and	O
the	O
numbers	O
of	O
infected	O
cells	O
were	O
determined	O
at	O
6	O
,	O
24	O
and	O
48	O
h	O
post	O
-	O
infection	B-DS
(	O
p	O
.	O
i	O
.).	O

Results	O
are	O
expressed	O
as	O
the	O
mean	O
number	O
of	O
infected	O
cells	O
in	O
triplicate	O
wells	O
+/−	O
SD	O
.	O

(	O
B	O
)	O
HepG2	O
cells	O
were	O
infected	O
with	O
WT	O
or	O
puf2	B-GP
(-)	O
sporozoites	O
and	O
the	O
numbers	O
of	O
infected	O
cells	O
were	O
determined	O
at	O
4	O
,	O
24	O
and	O
48	O
h	O
post	O
-	O
infection	B-DS
(	O
p	O
.	O
i	O
.).	O

Results	O
are	O
expressed	O
as	O
the	O
mean	O
number	O
of	O
infected	O
cells	O
in	O
triplicate	O
wells	O
+/−	O
SD	O
.	O

(	O
C	O
)	O
Confocal	O
microscopy	O
analysis	O
of	O
HepG2	O
cells	O
cultured	O
for	O
5	O
and	O
24	O
hours	O
post	O
-	O
infection	B-DS
(	O
p	O
.	O
i	O
.)	O
with	O
WT	O
,	O
puf1	B-GP
(-)	O
or	O
puf2	B-GP
(-)	O
sporozoites	O
,	O
using	O
antibodies	B-GP
against	O
UIS4	B-GP
(	O
red	O
),	O
CSP	B-GP
(	O
5	O
h	O
p	O
.	O
i	O
.,	O
green	O
)	O
or	O
HSP70	B-GP
(	O
24	O
h	O
p	O
.	O
i	O
.,	O
green	O
).	O

Nuclei	O
were	O
stained	O
with	O
DRAQ5	O
(	O
blue	O
).	O

Bars	O
,	O
10	O
µm	O
.	O

puf2	B-GP
(-)	O
sporozoites	O
transform	O
prematurely	O
in	O
the	O
mosquito	B-OG

In	O
vivo	O
data	O
suggested	O
that	O
,	O
over	O
time	O
,	O
Puf2	B-GP
-	O
knockout	O
sporozoites	O
rapidly	O
loose	O
infectivity	O
in	O
the	O
mosquito	B-OG
(	O
Table	O
1	O
).	O

To	O
better	O
characterize	O
this	O
phenomenon	O
,	O
we	O
carefully	O
analyzed	O
puf2	B-GP
(-)	O
sporozoite	O
development	O
in	O
the	O
mosquito	B-OG
(	O
Figure	O
6	O
).	O

Strikingly	O
,	O
we	O
observed	O
that	O
a	O
major	O
proportion	O
of	O
puf2	B-GP
(-)	O
sporozoites	O
showed	O
signs	O
of	O
premature	O
transformation	O
,	O
characterized	O
by	O
a	O
bulb	O
-	O
like	O
aspect	O
or	O
even	O
complete	O
rounding	O
-	O
up	O
(	O
Figure	O
6A	O
).	O

In	O
WT	O
parasites	O
,	O
transformation	O
of	O
sporozoites	O
is	O
typically	O
observed	O
at	O
37	O
°	O
C	O
in	O
culture	O
medium	O
,	O
irrespective	O
of	O
the	O
presence	O
of	O
host	O
cells	O
[	O
28	O
].	O

In	O
puf2	B-GP
(-)-	O
infected	O
mosquitoes	B-OG
,	O
however	O
,	O
the	O
proportion	O
of	O
transformed	O
sporozoites	O
increased	O
over	O
time	O
during	O
the	O
course	O
of	O
infection	B-DS
in	O
the	O
mosquitoes	B-OG
,	O
which	O
are	O
kept	O
at	O
20	O
°	O
C	O
(	O
Figure	O
6B	O
).	O

Quantification	O
of	O
partial	O
and	O
complete	O
transformation	O
in	O
all	O
three	O
parasite	O
populations	O
revealed	O
that	O
at	O
day	O
29	O
almost	O
all	O
puf2	B-GP
(-)	O
sporozoites	O
had	O
transformed	O
,	O
whereas	O
only	O
a	O
minor	O
fraction	O
of	O
WT	O
and	O
puf1	B-GP
(-)	O
sporozoites	O
exhibited	O
signs	O
of	O
premature	O
transformation	O
(	O
Figure	O
6B	O
).	O

Interestingly	O
,	O
we	O
did	O
not	O
observe	O
expression	O
of	O
the	O
liver	O
stage	O
marker	O
UIS4	B-GP
or	O
nuclear	O
divisions	O
,	O
as	O
seen	O
in	O
EEFs	O
(	O
Figure	O
5C	O
),	O
in	O
the	O
transformed	O
puf2	B-GP
(-)	O
sporozoites	O
(	O
Figure	O
6A	O
).	O

Premature	O
transformation	O
of	O
puf2	B-GP
(-)	O
sporozoites	O
in	O
the	O
mosquito	B-OG
.	O

(	O
A	O
)	O
Fluorescence	O
microscopy	O
of	O
WT	O
and	O
puf2	B-GP
(-)	O
sporozoites	O
isolated	O
from	O
mosquito	B-OG
salivary	O
glands	O
25	O
days	O
after	O
infection	B-DS
,	O
and	O
labelled	O
with	O
anti	O
-	O
UIS4	B-GP
(	O
red	O
)	O
and	O
anti	O
-	O
CSP	B-GP
(	O
green	O
)	O
antibodies	B-GP
.	O

Nuclei	O
were	O
stained	O
with	O
DRAQ5	O
(	O
blue	O
).	O

Bars	O
,	O
10	O
µm	O
.	O

(	O
B	O
)	O
The	O
proportion	O
of	O
non	O
-	O
transformed	O
,	O
partially	O
transformed	O
and	O
fully	O
transformed	O
sporozoites	O
was	O
determined	O
by	O
microscopic	O
examination	O
of	O
sporozoites	O
isolated	O
from	O
mosquito	B-OG
salivary	O
glands	O
18	O
,	O
21	O
,	O
25	O
or	O
29	O
days	O
after	O
infection	B-DS
with	O
WT	O
,	O
puf1	B-GP
(-)	O
or	O
puf2	B-GP
(-)	O
parasites	O
.	O

puf2	B-GP
(-)	O
sporozoites	O
have	O
reduced	O
levels	O
of	O
Puf1	B-GP
and	O
UIS1	B-GP
/	O
IK2	B-GP
mRNA	O

The	O
phenotype	O
of	O
puf2	B-GP
(-)	O
parasites	O
is	O
essentially	O
identical	O
to	O
that	O
of	O
parasites	O
that	O
contain	O
a	O
targeted	O
deletion	O
of	O
the	O
kinase	B-GP
UIS1	B-GP
/	O
IK2	B-GP
[	O
12	O
].	O

Similarly	O
to	O
puf2	B-GP
(-)	O
parasites	O
,	O
ik2	B-GP
(-)	O
sporozoites	O
transform	O
prematurely	O
in	O
the	O
mosquito	B-OG
salivary	O
glands	O
and	O
have	O
a	O
decreased	O
infectivity	O
in	O
vivo	O
but	O
not	O
in	O
vitro	O
[	O
12	O
].	O

Therefore	O
,	O
we	O
sought	O
to	O
test	O
expression	O
of	O
IK2	B-GP
in	O
puf2	B-GP
(-)	O
sporozoites	O
,	O
in	O
comparison	O
to	O
WT	O
and	O
puf1	B-GP
(-)	O
sporozoites	O
,	O
using	O
RT	O
-	O
qPCR	O
.	O

As	O
expected	O
from	O
gene	O
deletion	O
,	O
no	O
Puf1	B-GP
and	O
Puf2	B-GP
mRNA	O
were	O
detected	O
in	O
puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
sporozoites	O
,	O
respectively	O
(	O
Figure	O
7	O
).	O

Whereas	O
expression	O
of	O
UIS1	B-GP
/	O
IK2	B-GP
was	O
not	O
modified	O
in	O
puf1	B-GP
(-)	O
sporozoites	O
,	O
we	O
observed	O
a	O
∼	O
14	O
fold	O
reduction	O
of	O
UIS1	B-GP
/	O
IK2	B-GP
mRNA	O
in	O
Puf2	B-GP
-	O
deficient	O
sporozoites	O
as	O
compared	O
to	O
WT	O
(	O
Figure	O
7	O
).	O

Additionally	O
,	O
we	O
found	O
a	O
∼	O
17	O
fold	O
reduction	O
of	O
Puf1	B-GP
transcript	O
levels	O
in	O
puf2	B-GP
(-)	O
parasites	O
.	O

Conversely	O
,	O
Puf2	B-GP
transcript	O
levels	O
were	O
not	O
affected	O
in	O
the	O
absence	O
of	O
Puf1	B-GP
(	O
Figure	O
7	O
).	O

As	O
controls	O
,	O
UIS4	B-GP
and	O
HSP70	B-GP
mRNA	O
levels	O
were	O
similar	O
in	O
the	O
mutant	O
and	O
WT	O
sporozoites	O
.	O

Altogether	O
,	O
these	O
data	O
indicate	O
that	O
Puf2	B-GP
regulates	O
a	O
subset	O
of	O
genes	O
in	O
P	B-OG
.	I-OG
berghei	I-OG
sporozoites	O
,	O
including	O
Puf1	B-GP
and	O
the	O
kinase	B-GP
UIS1	B-GP
/	O
IK2	B-GP
.	O

The	O
latter	O
probably	O
explains	O
,	O
at	O
least	O
in	O
part	O
,	O
why	O
the	O
phenotype	O
of	O
puf2	B-GP
(-)	O
sporozoites	O
recapitulates	O
that	O
of	O
IK2	B-GP
-	O
knockout	O
parasites	O
.	O

puf2	B-GP
(-)	O
sporozoites	O
have	O
reduced	O
levels	O
of	O
Puf1	B-GP
and	O
UIS1	B-GP
/	O
IK2	B-GP
mRNA	O
.	O

Shown	O
is	O
an	O
expression	O
profiling	O
by	O
RT	O
-	O
qPCR	O
analysis	O
of	O
Puf1	B-GP
,	O
Puf2	B-GP
,	O
UIS1	B-GP
/	O
IK2	B-GP
,	O
UIS4	B-GP
and	O
HSP70	B-GP
mRNA	O
levels	O
in	O
WT	O
,	O
puf1	B-GP
(-)	O
and	O
puf2	B-GP
(-)	O
P	B-OG
.	I-OG
berghei	I-OG
sporozoites	O
.	O

Expression	O
data	O
from	O
three	O
independent	O
experiments	O
are	O
shown	O
and	O
were	O
normalized	O
to	O
the	O
level	O
of	O
GFP	B-GP
transcripts	O
,	O
which	O
are	O
expressed	O
under	O
the	O
control	O
of	O
the	O
EF1alpha	B-GP
promoter	O
[	O
26	O
].	O
no	O
amplif	O
.,	O
no	O
amplification	O
.	O

Discussion	O

Plasmodium	B-OG
sporozoites	O
must	O
persist	O
and	O
remain	O
infectious	O
within	O
the	O
salivary	O
glands	O
of	O
the	O
mosquito	B-OG
for	O
many	O
days	O
until	O
they	O
are	O
eventually	O
transmitted	O
to	O
a	O
mammalian	O
host	O
.	O

Inside	O
the	O
warm	O
-	O
blooded	O
host	O
they	O
need	O
to	O
quickly	O
leave	O
the	O
site	O
of	O
deposition	O
in	O
order	O
to	O
travel	O
to	O
the	O
liver	O
,	O
invade	O
hepatocytes	O
and	O
differentiate	O
into	O
liver	O
stages	O
[	O
29	O
].	O

The	O
transient	O
developmental	O
arrest	O
of	O
sporozoites	O
inside	O
mosquito	B-OG
salivary	O
glands	O
,	O
termed	O
latency	O
[	O
12	O
],	O
implies	O
efficient	O
control	O
mechanisms	O
to	O
prevent	O
premature	O
transformation	O
before	O
transmission	O
and	O
during	O
transmigration	O
before	O
reaching	O
a	O
suitable	O
host	O
cell	O
.	O

In	O
this	O
study	O
,	O
we	O
identified	O
a	O
factor	O
controlling	O
sporozoite	O
latency	O
in	O
P	B-OG
.	I-OG
berghei	I-OG
,	O
the	O
RNA	B-GP
-	I-GP
binding	I-GP
protein	I-GP
Puf2	B-GP
.	O

In	O
the	O
absence	O
of	O
Puf2	B-GP
,	O
sporozoites	O
transform	O
prematurely	O
in	O
the	O
mosquito	B-OG
,	O
resulting	O
in	O
a	O
severe	O
loss	O
of	O
infectivity	O
.	O

Sporozoite	O
conversion	O
into	O
liver	O
stages	O
requires	O
initial	O
remodelling	O
of	O
the	O
parasite	O
pellicle	O
,	O
with	O
disassembly	O
of	O
the	O
inner	O
membrane	O
complex	O
(	O
IMC	O
)	O
and	O
appearance	O
of	O
a	O
bulb	O
that	O
progressively	O
enlarges	O
until	O
the	O
initially	O
elongated	O
sporozoite	O
has	O
transformed	O
into	O
a	O
round	O
form	O
[	O
28	O
],	O
[	O
30	O
].	O

Previous	O
work	O
has	O
shown	O
that	O
transformation	O
of	O
salivary	O
gland	O
sporozoites	O
is	O
induced	O
at	O
37	O
°	O
C	O
in	O
culture	O
medium	O
,	O
irrespective	O
of	O
the	O
presence	O
of	O
host	O
cells	O
[	O
28	O
].	O

It	O
should	O
be	O
noted	O
that	O
differentiation	O
into	O
EEFs	O
involves	O
additional	O
events	O
,	O
including	O
expression	O
of	O
liver	O
stage	O
specific	O
proteins	O
,	O
onset	O
of	O
nuclear	O
divisions	O
and	O
parasite	O
growth	O
.	O

None	O
of	O
these	O
events	O
are	O
observed	O
in	O
axenic	O
culture	O
conditions	O
[	O
28	O
],	O
where	O
instead	O
extracellular	O
sporozoites	O
die	O
rapidly	O
after	O
transformation	O
[	O
31	O
].	O

We	O
show	O
that	O
puf2	B-GP
(-)	O
sporozoites	O
transform	O
prematurely	O
in	O
the	O
mosquito	B-OG
salivary	O
glands	O
,	O
as	O
evidenced	O
by	O
the	O
characteristic	O
bulb	O
-	O
like	O
structures	O
and	O
rounding	O
-	O
up	O
of	O
the	O
parasites	O
.	O

Premature	O
transformation	O
probably	O
impairs	O
the	O
sporozoite	O
functions	O
that	O
depend	O
on	O
IMC	O
integrity	O
,	O
such	O
as	O
parasite	O
motility	O
,	O
cell	O
traversal	O
and	O
invasion	O
,	O
thus	O
resulting	O
in	O
a	O
loss	O
of	O
infectivity	O
.	O

In	O
the	O
absence	O
of	O
Puf2	B-GP
,	O
the	O
proportion	O
of	O
transformed	O
salivary	O
gland	O
sporozoites	O
increases	O
over	O
time	O
,	O
which	O
correlates	O
with	O
a	O
progressive	O
loss	O
of	O
infectivity	O
to	O
mice	B-OG
.	O

Interestingly	O
,	O
although	O
most	O
puf2	B-GP
(-)	O
sporozoites	O
eventually	O
transform	O
into	O
completely	O
round	O
forms	O
,	O
these	O
forms	O
do	O
not	O
progress	O
to	O
EEF	O
differentiation	O
,	O
as	O
shown	O
by	O
minimal	O
expression	O
of	O
the	O
liver	O
stage	O
marker	O
UIS4	B-GP
and	O
absence	O
of	O
nuclear	O
division	O
or	O
growth	O
.	O

In	O
contrast	O
,	O
normal	O
differentiation	O
of	O
puf2	B-GP
(-)	O
parasites	O
is	O
observed	O
once	O
sporozoites	O
invade	O
cultured	O
hepatoma	B-DS
cells	O
.	O

Collectively	O
,	O
these	O
data	O
strongly	O
suggest	O
that	O
Puf2	B-GP
plays	O
a	O
major	O
role	O
in	O
preventing	O
premature	O
remodelling	O
of	O
the	O
sporozoites	O
prior	O
to	O
liver	B-DS
infection	I-DS
,	O
but	O
is	O
not	O
required	O
for	O
EEF	O
differentiation	O
.	O

The	O
defects	O
observed	O
in	O
puf2	B-GP
(-)	O
parasites	O
are	O
reminiscent	O
of	O
those	O
described	O
in	O
IK2	B-GP
-	O
knockout	O
parasites	O
[	O
12	O
].	O

Both	O
puf2	B-GP
(-)	O
and	O
ik2	B-GP
(-)	O
sporozoites	O
transform	O
prematurely	O
in	O
the	O
mosquito	B-OG
and	O
display	O
greatly	O
reduced	O
infectivity	O
to	O
mice	B-OG
.	O

However	O
,	O
both	O
loss	O
-	O
of	O
-	O
function	O
mutants	O
are	O
able	O
to	O
invade	O
and	O
differentiate	O
into	O
EEFs	O
in	O
cultured	O
cells	O
in	O
vitro	O
,	O
indicating	O
that	O
they	O
do	O
not	O
play	O
any	O
essential	O
role	O
after	O
host	O
cell	O
infection	B-DS
.	O

These	O
observations	O
,	O
combined	O
with	O
a	O
major	O
down	O
-	O
regulation	O
of	O
IK2	B-GP
expression	O
in	O
puf2	B-GP
(-)	O
sporozoites	O
,	O
suggest	O
that	O
the	O
phenotype	O
of	O
Puf2	B-GP
-	O
deficient	O
parasites	O
can	O
be	O
explained	O
,	O
to	O
a	O
large	O
extent	O
,	O
by	O
IK2	B-GP
depletion	O
.	O

How	O
IK2	B-GP
prevents	O
sporozoite	O
transformation	O
has	O
yet	O
to	O
be	O
determined	O
.	O

Phosphorylation	O
of	O
the	O
alpha	O
subunit	O
of	O
eIF2	B-GP
by	O
distinct	O
kinases	B-GP
,	O
such	O
as	O
Plasmodium	B-OG
IK2	B-GP
,	O
is	O
a	O
central	O
mechanism	O
in	O
stress	O
-	O
induced	O
translational	O
regulation	O
[	O
32	O
],	O
including	O
in	O
protozoans	O
.	O

For	O
example	O
,	O
the	O
eIF2alpha	B-GP
kinase	I-GP
IK1	B-GP
regulates	O
responses	O
to	O
starvation	O
stress	O
in	O
P	B-OG
.	I-OG
falciparum	I-OG
blood	O
stages	O
[	O
13	O
],	O
and	O
in	O
Toxoplasma	B-OG
gondii	I-OG
,	O
phosphorylation	O
of	O
eIF2alpha	B-GP
promotes	O
survival	O
of	O
extracellular	O
tachyzoites	O
[	O
33	O
].	O

Our	O
data	O
corroborate	O
the	O
findings	O
of	O
Zhang	O
et	O
al	O
.	O
[	O
12	O
],	O
which	O
together	O
suggest	O
that	O
a	O
similar	O
stress	O
response	O
operates	O
in	O
sporozoites	O
to	O
maintain	O
them	O
in	O
a	O
quiescent	O
stage	O
.	O

The	O
founding	O
member	O
of	O
the	O
Puf	B-GP
family	O
,	O
Drosophila	B-OG
melanogaster	I-OG
Pumilio	B-GP
(	O
DmPUM	B-GP
),	O
regulates	O
,	O
amongst	O
other	O
functions	O
,	O
abdominal	O
development	O
in	O
the	O
fly	B-OG
via	O
translational	O
repression	O
of	O
the	O
maternally	O
inherited	O
hunchback	B-GP
(	O
hb	B-GP
)	O
mRNA	O
[	O
34	O
].	O

The	O
Puf	B-GP
domain	O
of	O
DmPUM	B-GP
binds	O
to	O
a	O
nanos	O
response	O
element	O
(	O
NRE	O
)	O
sequence	O
located	O
in	O
the	O
3	O
′	O
UTR	O
of	O
hb	B-GP
mRNA	O
.	O

Biochemical	O
data	O
,	O
such	O
as	O
in	O
vitro	O
binding	O
assays	O
using	O
recombinant	O
Puf	B-GP
domains	O
expressed	O
in	O
bacteria	B-OG
and	O
heterologous	O
in	O
vivo	O
studies	O
using	O
the	O
yeast	B-OG
three	O
-	O
hybrid	O
system	O
,	O
have	O
demonstrated	O
intrinsic	O
binding	O
activity	O
of	O
the	O
P	B-OG
.	I-OG
falciparum	I-OG
PfPuf1	B-GP
and	O
PfPuf2	B-GP
to	O
the	O
NRE	O
sequence	O
[	O
20	O
],	O
[	O
21	O
].	O

Signature	O
RNA	O
sequences	O
that	O
are	O
recognized	O
by	O
the	O
Puf	B-GP
domain	O
vary	O
between	O
species	O
and	O
members	O
of	O
the	O
Puf	B-GP
family	O
,	O
but	O
typically	O
contain	O
a	O
UGUR	O
motif	O
[	O
35	O
],	O
[	O
36	O
],	O
[	O
37	O
],	O
[	O
38	O
].	O

A	O
large	O
number	O
of	O
Plasmodium	B-OG
genes	O
contain	O
UGUR	O
motifs	O
in	O
their	O
3	O
′	O
UTR	O
,	O
but	O
their	O
functional	O
significance	O
remains	O
uncertain	O
,	O
especially	O
in	O
the	O
context	O
of	O
the	O
exceptional	O
AT	O
-	O
richness	O
of	O
the	O
Plasmodium	B-OG
genome	O
.	O

Therefore	O
,	O
endogenous	O
targets	O
of	O
Plasmodium	B-OG
Puf	B-GP
proteins	O
still	O
remain	O
elusive	O
.	O

The	O
P	B-OG
.	I-OG
falciparum	I-OG
[	O
22	O
]	O
and	O
P	B-OG
.	I-OG
berghei	I-OG
(	O
this	O
study	O
)	O
mutants	O
now	O
constitute	O
potential	O
tools	O
to	O
identify	O
Puf2	B-GP
target	O
genes	O
in	O
Plasmodium	B-OG
.	O

In	O
sporozoites	O
,	O
Puf2	B-GP
regulates	O
at	O
least	O
two	O
other	O
genes	O
in	O
addition	O
to	O
IK2	B-GP
and	O
Puf1	B-GP
.	O

Indeed	O
,	O
using	O
RT	O
-	O
qPCR	O
,	O
we	O
found	O
a	O
4	O
-	O
fold	O
reduction	O
of	O
Spect	B-GP
and	O
Spect2	B-GP
mRNA	O
levels	O
in	O
puf2	B-GP
(-)	O
sporozoites	O
,	O
whereas	O
actin	B-GP
and	O
AMA1	B-GP
were	O
not	O
affected	O
(	O
unpublished	O
data	O
).	O

Reduced	O
expression	O
of	O
Spect	B-GP
and	O
Spect2	B-GP
genes	O
,	O
which	O
are	O
both	O
essential	O
for	O
sporozoite	O
cell	O
traversal	O
and	O
migration	O
to	O
the	O
liver	O
[	O
29	O
],	O
[	O
39	O
],	O
[	O
40	O
],	O
may	O
also	O
contribute	O
to	O
the	O
loss	O
of	O
infectivity	O
of	O
puf2	B-GP
(-)	O
parasites	O
in	O
vivo	O
.	O

Whereas	O
Puf	B-GP
proteins	O
typically	O
modulate	O
target	O
mRNA	O
expression	O
by	O
either	O
promoting	O
mRNA	O
turnover	O
or	O
translational	O
repression	O
,	O
they	O
can	O
also	O
activate	O
gene	O
expression	O
or	O
control	O
mRNA	O
subcellular	O
localization	O
(	O
reviewed	O
in	O
[	O
18	O
]	O
and	O
[	O
19	O
]).	O

Our	O
results	O
are	O
not	O
compatible	O
with	O
a	O
role	O
of	O
Puf2	B-GP
in	O
repressing	O
IK2	B-GP
,	O
because	O
puf2	B-GP
(-)	O
and	O
ik2	B-GP
(-)	O
share	O
a	O
similar	O
phenotype	O
.	O

Puf2	B-GP
may	O
instead	O
participate	O
in	O
stabilization	O
of	O
IK2	B-GP
transcripts	O
.	O

Alternatively	O
,	O
depletion	O
of	O
IK2	B-GP
mRNA	O
in	O
puf2	B-GP
(-)	O
could	O
be	O
an	O
indirect	O
effect	O
due	O
to	O
activation	O
of	O
an	O
upstream	O
factor	O
that	O
regulates	O
IK2	B-GP
.	O

Whereas	O
Drosophila	B-OG
encodes	O
only	O
DmPUM	B-GP
,	O
many	O
organisms	O
,	O
including	O
C	B-OG
.	I-OG
elegans	I-OG
,	O
contain	O
two	O
or	O
more	O
genes	O
encoding	O
Puf	B-GP
proteins	O
,	O
which	O
can	O
fulfil	O
partly	O
redundant	O
functions	O
[	O
41	O
].	O

Therefore	O
,	O
presence	O
of	O
two	O
Puf	B-GP
genes	O
in	O
the	O
Plasmodium	B-OG
genome	O
might	O
be	O
explained	O
by	O
overlapping	O
or	O
distinct	O
roles	O
.	O

However	O
,	O
our	O
molecular	O
genetics	O
data	O
clearly	O
exclude	O
a	O
vital	O
role	O
for	O
Puf1	B-GP
under	O
normal	O
conditions	O
throughout	O
the	O
P	B-OG
.	I-OG
berghei	I-OG
life	O
cycle	O
.	O
Puf1	B-GP
may	O
be	O
critical	O
under	O
specific	O
conditions	O
,	O
similarly	O
to	O
the	O
role	O
of	O
IK1	B-GP
in	O
P	B-OG
.	I-OG
falciparum	I-OG
during	O
starvation	O
-	O
induced	O
stress	O
[	O
13	O
].	O

Puf2	B-GP
might	O
compensate	O
for	O
the	O
absence	O
of	O
Puf1	B-GP
in	O
puf1	B-GP
(-)	O
parasites	O
,	O
but	O
not	O
vice	O
versa	O
.	O

While	O
Puf1	B-GP
in	O
principle	O
might	O
be	O
able	O
to	O
functionally	O
complement	O
for	O
Puf2	B-GP
function	O
,	O
depletion	O
of	O
Puf1	B-GP
at	O
the	O
mRNA	O
level	O
precludes	O
a	O
hypothetical	O
functional	O
overlap	O
in	O
vivo	O
.	O
In	O
this	O
regard	O
,	O
it	O
should	O
be	O
noted	O
that	O
P	B-OG
.	I-OG
berghei	I-OG
Puf1	B-GP
and	O
Puf2	B-GP
proteins	O
are	O
very	O
different	O
in	O
size	O
(	O
1183	O
versus	O
477	O
amino	O
acids	O
,	O
respectively	O
),	O
and	O
share	O
only	O
little	O
homology	O
(∼	O
27	O
%	O
identity	O
)	O
restricted	O
to	O
the	O
Puf	B-GP
domains	O
.	O

P	B-OG
.	I-OG
falciparum	I-OG
parasites	O
that	O
lack	O
Puf2	B-GP
show	O
increased	O
gametocyte	O
rates	O
and	O
a	O
bias	O
towards	O
male	O
gametocytes	O
[	O
22	O
].	O

These	O
observations	O
fit	O
with	O
the	O
proposed	O
unifying	O
,	O
and	O
perhaps	O
ancestral	O
,	O
role	O
of	O
Pufs	B-GP
in	O
promoting	O
cell	O
proliferation	O
and	O
repressing	O
differentiation	O
[	O
18	O
].	O

Our	O
findings	O
that	O
Puf2	B-GP
inhibits	O
sporozoite	O
transformation	O
further	O
support	O
the	O
notion	O
of	O
a	O
central	O
role	O
in	O
suppression	O
of	O
cellular	O
differentiation	O
.	O

Because	O
of	O
the	O
published	O
data	O
from	O
P	B-OG
.	I-OG
falciparum	I-OG
puf2	B-GP
(-)	O
parasites	O
we	O
did	O
not	O
investigate	O
sexual	O
development	O
and	O
differentiation	O
of	O
Pbpuf2	B-GP
(-)	O
parasites	O
in	O
great	O
detail	O
other	O
than	O
to	O
confirm	O
the	O
previous	O
findings	O
,	O
i	O
.	O
e	O
.	O
an	O
increase	O
in	O
gametocytogenesis	O
in	O
puf2	B-GP
(-)	O
parasites	O
,	O
partly	O
due	O
to	O
increased	O
male	O
gametocyte	O
differentiation	O
.	O

In	O
the	O
previous	O
study	O
,	O
life	O
cycle	O
progression	O
of	O
Pfpuf2	B-GP
(-)	O
parasites	O
beyond	O
gametocytogenesis	O
was	O
not	O
analyzed	O
[	O
22	O
].	O

Based	O
on	O
our	O
results	O
in	O
the	O
rodent	B-OG
malaria	B-DS
model	O
system	O
,	O
we	O
predict	O
that	O
P	B-OG
.	I-OG
falciparum	I-OG
sporozoites	O
lacking	O
Puf2	B-GP
will	O
present	O
a	O
similar	O
phenotype	O
,	O
that	O
is	O
premature	O
sporozoite	O
transformation	O
in	O
the	O
mosquito	B-OG
and	O
decreased	O
infectivity	O
.	O

Therefore	O
,	O
our	O
findings	O
might	O
be	O
of	O
considerable	O
interest	O
in	O
the	O
context	O
of	O
development	O
of	O
genetically	O
attenuated	O
parasites	O
for	O
vaccination	O
[	O
42	O
].	O

In	O
conclusion	O
,	O
we	O
show	O
here	O
that	O
Puf2	B-GP
plays	O
a	O
major	O
role	O
in	O
controlling	O
sporozoite	O
latency	O
during	O
host	O
switch	O
,	O
possibly	O
through	O
the	O
regulation	O
of	O
IK2	B-GP
.	O

Our	O
results	O
also	O
highlight	O
the	O
functional	O
importance	O
of	O
post	O
-	O
transcriptional	O
regulation	O
of	O
gene	O
expression	O
during	O
transmission	O
of	O
the	O
malaria	B-DS
parasite	O
between	O
hosts	O
.	O

Materials	O
and	O
Methods	O

Ethics	O
statement	O

All	O
animal	B-OG
work	O
was	O
conducted	O
in	O
accordance	O
with	O
the	O
German	O
‘	O
Tierschutzgesetz	O
in	O
der	O
Fassung	O
vom	O
18	O
.	O

Mai	O
2006	O
(	O
BGBl	O
.	O

I	O
S	O
.	O

1207	O
)',	O
which	O
implements	O
the	O
directive	O
86	O
/	O
609	O
/	O
EEC	O
from	O
the	O
European	O
Union	O
and	O
the	O
European	O
Convention	O
for	O
the	O
protection	O
of	O
vertebrate	B-OG
animals	B-OG
used	O
for	O
experimental	O
and	O
other	O
scientific	O
purposes	O
.	O

The	O
protocol	O
was	O
approved	O
by	O
the	O
ethics	O
committee	O
of	O
MPI	O
-	O
IB	O
and	O
the	O
Berlin	O
state	O
authorities	O
(	O
LAGeSo	O
Reg	O
#	O
G0469	O
/	O
09	O
).	O

Experimental	O
animals	B-OG
,	O
parasites	O
and	O
cell	O
lines	O

Female	O
NMRI	O
and	O
C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
were	O
from	O
Charles	O
River	O
Laboratories	O
.	O

We	O
used	O
P	B-OG
.	I-OG
berghei	I-OG
ANKA	I-OG
clone	I-OG
507	I-OG
parasites	O
,	O
which	O
constitutively	O
express	O
the	O
green	B-GP
fluorescent	I-GP
protein	I-GP
(	O
GFP	B-GP
)	O
[	O
26	O
].	O

HepG2	O
cells	O
(	O
ATCC	O
HB	B-GP
-	O
8065	O
)	O
were	O
cultured	O
as	O
described	O
[	O
43	O
].	O

P	B-OG
.	I-OG
berghei	I-OG
Puf1	B-GP
and	O
Puf2	B-GP
gene	O
deletion	O

A	O
targeting	O
construct	O
for	O
Puf1	B-GP
gene	O
knockout	O
was	O
generated	O
by	O
inserting	O
a	O
503	O
-	O
bp	O
5	O
′	O
fragment	O
and	O
a	O
575	O
-	O
bp	O
3	O
′	O
fragment	O
on	O
either	O
side	O
of	O
a	O
T	B-OG
.	I-OG
gondii	I-OG
DHFR	B-GP
/	O
TS	B-GP
expression	O
cassette	O
.	O

A	O
construct	O
for	O
Puf2	B-GP
gene	O
knockout	O
was	O
generated	O
by	O
inserting	O
a	O
1001	O
-	O
bp	O
5	O
′	O
fragment	O
and	O
a	O
945	O
-	O
bp	O
3	O
′	O
fragment	O
on	O
either	O
side	O
of	O
a	O
human	B-OG
DHFR	B-GP
expression	O
cassette	O
.	O

Oligonucleotide	O
sequences	O
are	O
indicated	O
in	O
Table	O
S1	O
.	O
P	B-OG
.	I-OG
berghei	I-OG
parasites	O
were	O
transfected	O
with	O
linearized	O
plasmids	O
,	O
using	O
the	O
Nucleofector	O
®	O
device	O
(	O
Amaxa	O
GmbH	O
)	O
as	O
described	O
[	O
44	O
],	O
injected	O
intravenously	O
into	O
naïve	O
NMRI	B-OG
mice	I-OG
,	O
and	O
selected	O
by	O
pyrimethamine	O
treatment	O
in	O
the	O
drinking	O
water	O
.	O

Clonal	O
parasite	O
populations	O
were	O
obtained	O
by	O
limiting	O
dilution	O
series	O
and	O
intravenous	O
injection	O
of	O
one	O
parasite	O
in	O
10	O
recipient	O
NMRI	B-OG
mice	I-OG
.	O

One	O
puf1	B-GP
(-)	O
and	O
two	O
puf2	B-GP
(-)	O
clonal	O
parasite	O
lines	O
were	O
established	O
and	O
phenotypically	O
characterized	O
.	O

Genotyping	O
of	O
WT	O
and	O
recombinant	O
parasites	O
was	O
performed	O
by	O
PCR	O
and	O
Southern	O
blot	O
analysis	O
of	O
genomic	O
DNA	O
.	O

Standard	O
Southern	O
blot	O
analysis	O
was	O
performed	O
using	O
the	O
PCR	O
DIG	O
Probe	O
synthesis	O
kit	O
and	O
the	O
DIG	O
Luminescent	O
Detection	O
kit	O
(	O
Roche	O
),	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Real	O
time	O
quantitative	O
RT	O
-	O
PCR	O

Parasite	O
total	O
RNA	O
was	O
extracted	O
with	O
the	O
RNeasy	O
kit	O
(	O
Qiagen	O
)	O
and	O
reverse	O
transcribed	O
with	O
the	O
RETROScript	O
kit	O
(	O
Ambion	O
).	O

Real	O
time	O
PCR	O
was	O
performed	O
on	O
cDNA	O
preparations	O
as	O
described	O
[	O
11	O
],	O
using	O
the	O
StepOnePlus	O
™	O
Real	O
-	O
Time	O
PCR	O
System	O
and	O
Power	O
SYBR	O
®	O
Green	O
PCR	O
Master	O
Mix	O
(	O
Applied	O
Biosystems	O
),	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
.	O

Expression	O
data	O
were	O
normalized	O
using	O
the	O
constitutively	O
expressed	O
GFP	B-GP
gene	O
.	O

Immunofluorescence	O

Parasites	O
were	O
fixed	O
in	O
4	O
%	O
paraformaldehyde	O
(	O
PFA	O
)	O
and	O
permeabilized	O
with	O
1	O
%	O
Triton	O
X	O
-	O
100	O
.	O

Immunofluorescence	O
was	O
then	O
carried	O
out	O
using	O
previously	O
described	O
monoclonal	O
antibodies	B-GP
against	O
P	B-OG
.	I-OG
berghei	I-OG
CSP	B-GP
[	O
45	O
]	O
and	O
HSP70	B-GP
[	O
46	O
].	O

Polyclonal	O
anti	O
-	O
UIS4	B-GP
antibodies	B-GP
were	O
raised	O
in	O
rabbits	B-OG
immunized	O
with	O
two	O
synthetic	O
peptides	O
from	O
P	B-OG
.	I-OG
berghei	I-OG
UIS4	B-GP
(	O
CLFTDEHKDEINDNIV	O
and	O
CNNVYNMENKSFGPYI	O
)	O
(	O
Eurogentec	O
).	O

DRAQ5	O
(	O
Biostatus	O
)	O
was	O
used	O
to	O
stain	O
nuclei	O
.	O

Confocal	O
pictures	O
were	O
obtained	O
with	O
a	O
Leica	O
TCS	O
-	O
SP	B-GP
microscope	O
equipped	O
with	O
appropriate	O
filters	O
,	O
and	O
processed	O
with	O
Photoshop	O
software	O
(	O
Adobe	O
Inc	O
.).	O

Parasite	O
growth	O
and	O
sexual	O
development	O

C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
(	O
n	O
=	O
5	O
)	O
were	O
injected	O
intravenously	O
with	O
107	O
infected	O
erythrocytes	O
.	O

Four	O
days	O
later	O
,	O
the	O
parasitemia	B-DS
was	O
determined	O
by	O
microscopic	O
examination	O
of	O
Giemsa	O
-	O
stained	O
blood	O
smears	O
.	O

To	O
analyse	O
exflagellation	O
of	O
male	O
gametocytes	O
,	O
five	O
microliters	O
of	O
tail	O
blood	O
were	O
diluted	O
1	O
∶	O
25	O
in	O
RPMI	O
1640	O
containing	O
10	O
%	O
FCS	O
and	O
50	O
µM	O
xanthurenic	O
acid	O
,	O
and	O
adjusted	O
to	O
pH	O
8	O
.	O
0	O
.	O

After	O
12	O
min	O
incubation	O
at	O
room	O
temperature	O
,	O
exflagellation	O
centers	O
were	O
counted	O
in	O
a	O
Neubauer	O
chamber	O
.	O

Mean	O
parasitemia	B-DS
and	O
gametocyte	O
rates	O
were	O
compared	O
using	O
the	O
Mann	O
-	O
Whitney	O
non	O
-	O
parametric	O
test	O
.	O

After	O
parasite	O
transmission	O
to	O
Anopheles	B-OG
stephensi	I-OG
mosquitoes	B-OG
,	O
the	O
numbers	O
of	O
midgut	O
oocysts	O
and	O
salivary	O
gland	O
sporozoites	O
were	O
determined	O
at	O
day	O
10	O
–	O
14	O
and	O
day	O
18	O
–	O
25	O
,	O
respectively	O
,	O
and	O
compared	O
using	O
the	O
Kruskal	O
-	O
Wallis	O
followed	O
by	O
Dunn	O
'	O
s	O
multiple	O
comparison	O
tests	O
.	O

Analysis	O
of	O
sporozoite	O
in	O
vivo	O
infectivity	O

C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
were	O
injected	O
intravenously	O
with	O
1	O
,	O
000	O
WT	O
or	O
mutant	O
sporozoites	O
isolated	O
from	O
the	O
salivary	O
glands	O
of	O
infected	O
mosquitoes	B-OG
,	O
or	O
exposed	O
to	O
10	O
infected	O
mosquito	B-OG
bites	O
,	O
as	O
indicated	O
.	O

Infection	B-DS
was	O
then	O
monitored	O
daily	O
by	O
examination	O
of	O
Giemsa	O
-	O
stained	O
blood	O
smears	O
.	O

The	O
delay	O
of	O
patency	O
was	O
defined	O
as	O
the	O
time	O
before	O
detection	O
of	O
at	O
least	O
one	O
erythrocytic	O
stage	O
in	O
the	O
smears	O
.	O

For	O
quantification	O
of	O
parasite	O
liver	O
loads	O
by	O
real	O
time	O
RT	O
-	O
PCR	O
,	O
C57BL	B-OG
/	I-OG
6	I-OG
mice	I-OG
were	O
infected	O
intravenously	O
with	O
10	O
,	O
000	O
sporozoites	O
.	O

At	O
42	O
hours	O
post	O
-	O
infection	B-DS
,	O
livers	O
were	O
harvested	O
,	O
total	O
RNA	O
was	O
extracted	O
with	O
the	O
RNeasy	O
kit	O
(	O
Qiagen	O
)	O
and	O
cDNA	O
synthesized	O
with	O
the	O
RETROScript	O
kit	O
(	O
Ambion	O
).	O

Real	O
-	O
time	O
PCR	O
was	O
then	O
performed	O
with	O
the	O
StepOnePlus	O
™	O
Real	O
-	O
Time	O
PCR	O
System	O
and	O
Power	O
SYBR	O
®	O
Green	O
PCR	O
Master	O
Mix	O
(	O
Applied	O
Biosystems	O
),	O
using	O
primers	O
specific	O
for	O
P	B-OG
.	I-OG
berghei	I-OG
18S	O
rRNA	O
and	O
mouse	B-OG
GAPDH	B-GP
,	O
as	O
described	O
[	O
47	O
].	O

Liver	O
parasite	O
loads	O
were	O
compared	O
using	O
the	O
Mann	O
-	O
Whitney	O
non	O
-	O
parametric	O
test	O
.	O

Supporting	O
Information	O

List	O
of	O
oligonucleotides	O
used	O
in	O
this	O
study	O
.	O

(	O
PDF	O
)	O

Click	O
here	O
for	O
additional	O
data	O
file	O
.	O

Competing	O
Interests	O
:	O
The	O
authors	O
have	O
declared	O
that	O
no	O
competing	O
interests	O
exist	O
.	O

